Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy

NCT00031863 is registered in ClinicalTrials.gov with Cancer Research Campaign Clinical Trials Centre as lead sponsor.

NCT NCT00031863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, Double Blind, Placebo Controlled Study of Rofecoxib in Colorectal Cancer Patients Following Adjuvant Chemotherapy
Lead sponsor
Cancer Research Campaign Clinical Trials Centre
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2001
Completion date
September 30, 2007
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer